Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liam R Brunham

Showing results (61-70 of 156) with videos related to

Pageof 16
Sort By:
European Journal of Preventive Cardiology|February 25, 2025
Reappraisal of statin primary prevention trials: implications for identification of the statin-eligible primary prevention patientG B John Mancini, Arnold Ryomoto, Eunice Yeoh, et al.
Journal of Clinical Lipidology|January 14, 2022
Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysisLatifah Alothman, Alexandre M Bélanger, Isabelle Ruel, et al.
Journal of Critical Care|December 26, 2016
Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsisMihai Cirstea, Keith R Walley, James A Russell, et al.
Plos Genetics|January 24, 2006
Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 geneLiam R Brunham, Roshni R Singaraja, Terry D Pape, et al.
JACC. Advances|June 28, 2024
Longitudinal Control of Lipid Levels in Patients With Premature Coronary Artery DiseaseDiana N Vikulova, Danielle Pinheiro-Muller, Carlos Rojas-Fernandez, et al.
Circulation Research|September 2, 2006
Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levelsLiam R Brunham, Janine K Kruit, Terry D Pape, et al.
Circulation. Genomic and Precision Medicine|October 20, 2020
Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial HypercholesterolemiaMark Trinder, Martine Paquette, Lubomira Cermakova, et al.
American Journal of Preventive Cardiology|March 2, 2026
Polygenic risk score predicts presence of subclinical atherosclerosis in first-degree relatives of patients with premature coronary artery diseaseDiana N Vikulova, Nicol Vaizman, Mark E Trinder, et al.
European Journal of Human Genetics : EJHG|December 7, 2024
Knowledge, attitudes and demand toward cardiovascular polygenic risk testing in clinical practice: cross-sectional survey of patientsShanjot Brar, Jared Townsend, Joban Phulka, et al.
CJC Open|March 15, 2024
The Importance of Nontraditional and Sex-Specific Risk Factors in Young Women With Vasomotor Nonobstructive vs Obstructive Coronary SyndromesEmilie T Théberge, Diana N Vikulova, Simon N Pimstone, et al.
Pageof 16

Showing results (61-70 of 156) with videos related to

Sort By:
Pageof 16
European Journal of Preventive Cardiology|February 25, 2025
Reappraisal of statin primary prevention trials: implications for identification of the statin-eligible primary prevention patientG B John Mancini, Arnold Ryomoto, Eunice Yeoh, et al.
Journal of Clinical Lipidology|January 14, 2022
Health-related quality of life in homozygous familial hypercholesterolemia: A systematic review and meta-analysisLatifah Alothman, Alexandre M Bélanger, Isabelle Ruel, et al.
Journal of Critical Care|December 26, 2016
Decreased high-density lipoprotein cholesterol level is an early prognostic marker for organ dysfunction and death in patients with suspected sepsisMihai Cirstea, Keith R Walley, James A Russell, et al.
Plos Genetics|January 24, 2006
Accurate prediction of the functional significance of single nucleotide polymorphisms and mutations in the ABCA1 geneLiam R Brunham, Roshni R Singaraja, Terry D Pape, et al.
JACC. Advances|June 28, 2024
Longitudinal Control of Lipid Levels in Patients With Premature Coronary Artery DiseaseDiana N Vikulova, Danielle Pinheiro-Muller, Carlos Rojas-Fernandez, et al.
Circulation Research|September 2, 2006
Tissue-specific induction of intestinal ABCA1 expression with a liver X receptor agonist raises plasma HDL cholesterol levelsLiam R Brunham, Janine K Kruit, Terry D Pape, et al.
Circulation. Genomic and Precision Medicine|October 20, 2020
Polygenic Contribution to Low-Density Lipoprotein Cholesterol Levels and Cardiovascular Risk in Monogenic Familial HypercholesterolemiaMark Trinder, Martine Paquette, Lubomira Cermakova, et al.
American Journal of Preventive Cardiology|March 2, 2026
Polygenic risk score predicts presence of subclinical atherosclerosis in first-degree relatives of patients with premature coronary artery diseaseDiana N Vikulova, Nicol Vaizman, Mark E Trinder, et al.
European Journal of Human Genetics : EJHG|December 7, 2024
Knowledge, attitudes and demand toward cardiovascular polygenic risk testing in clinical practice: cross-sectional survey of patientsShanjot Brar, Jared Townsend, Joban Phulka, et al.
CJC Open|March 15, 2024
The Importance of Nontraditional and Sex-Specific Risk Factors in Young Women With Vasomotor Nonobstructive vs Obstructive Coronary SyndromesEmilie T Théberge, Diana N Vikulova, Simon N Pimstone, et al.
Pageof 16